Home > Insider Trading > Filing (0001140361-11-045424)

Filing Details

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
890846	Uroplasty Inc	UPI	Surgical & Medical Instruments & Apparatus (3841)	411719250

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1205664	Hartjes Susan Holman	Uroplasty, Inc 5420 Feltl Road Minnetonka MN 55343	Chief Operating Officer	No	Yes	No	No

Reported Non-Derivative Transactions

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
Common Stock	Disposition	2011-09-09	7,229	$5.20	309,680	No	4	S	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
No	4	S	Direct

Reported Derivative Holdings

Sec. Name	Sec. Type	Price	Date	Expiration Date	Amount	Remaning Holdings	Nature of Ownership
Common Stock	non-qualified stock options	$5.19		2015-01-01	100,000	100,000	Direct
Common Stock	non-qualified stock options	$2.65		2014-02-01	12,500	12,500	Direct
Common Stock	non-qualified stock options	$3.15		2013-06-23	10,000	10,000	Direct
Common Stock	non-qualified stock options	$0.85		2014-06-04	40,000	40,000	Direct
Common Stock	non-qualified stock options	$4.94	2011-06-08	2017-06-07	6,525	6,525	Direct
Common Stock	non-qualified stock option	$7.98	2012-06-07	2018-06-06	4,100	4,100	Direct

Expiration Date	Amount	Remaning Holdings	Nature of Ownership
2015-01-01	100,000	100,000	Direct
2014-02-01	12,500	12,500	Direct
2013-06-23	10,000	10,000	Direct
2014-06-04	40,000	40,000	Direct
2017-06-07	6,525	6,525	Direct
2018-06-06	4,100	4,100	Direct

Footnotes

Includes 3,825 shares of restricted stock subject to risk of forfeiture that lapses with respect to one third of such shares on each of the second, third and fourth anniversaries of the grant date (June 8, 2010).
Includes 3,150 shares of restricted stock subject to risk of forfeiture that lapses with respect to one fourth of such shares on each of the first, second, third and fourth anniversaries of the grant date (June 7, 2011).
Fully vested.
Becomes exercisable with respect to one-third of the shares on the first, second and third anniversaries of the grant date (the grant date being one year prior to such date).
The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $5.19 to $5.22 per share, inclusive. The reporting person undertakes to provide to Uroplasty, Inc., any security holder of Uroplasty, Inc, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote (5).